ASNB

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 1/05/2017
Contact Info
  • 229 Andover Street
  • Wilmington, MA 01887

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-Q
CIK 0001011060
Fiscal Year End 3/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. 1996
Employees 12 a/o Dec 09, 2016
Company Officers/Contacts
Michael F. Adams President, CEO
David Volpe Consultant
Investor Relations IR
Company Directors
William J. O'Neill, Jr. Chairman, Independent Director, Audit Committee Member
Service Providers
Accounting/Auditing Firm
RBSM LLP
805 Third Avenue
Suite 902
New York, NY, 10022
United States
 
Securities Counsel
Seyfarth Shaw LLP
Two Seaport Lane
Suite 300
Boston, MA, 02210
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Cardiotech International, Inc. until 10-2008
ASNB Security Details
Share Structure
Market Value1 $1,246,456 a/o Jun 23, 2017
Authorized Shares 50,000,000 a/o Dec 09, 2016
Outstanding Shares 21,490,621 a/o Feb 09, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 20,910,572 a/o Dec 09, 2016
Par Value 0.01
Shareholders
Shareholders of Record 335 a/o Dec 09, 2016
Short Selling Data
Short Interest 7,107 (-1.39%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security